Incyte to Present at Upcoming Investor Conferences
- Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 1, 2008 at 10:40 a.m. (ET) in Key Biscayne, Florida;
- Banc of America 2008 Healthcare Conference on Wednesday, May 14, 2008 at 2:40 p.m. (PT) / 5:40 p.m. (ET) in Las Vegas; and
- JMP Securities Seventh Annual Research Conference on Tuesday, May 20, 2008 at 9:30 a.m. (PT) / 12:30 p.m. (ET) in San Francisco.
The presentations will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentations will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Incyte's pipeline includes multiple compounds in Phase I and Phase II development for oncology, inflammation, diabetes and HIV. For additional information on Incyte, visit the Company's web site at www.incyte.com.
CONTACT:
Incyte Corporation
Pamela M. Murphy
Vice President,
Investor Relations/Corporate Communications
302-498-6944
SOURCE: Incyte Corporation